Fertility and Sterility
Volume 93, Issue 4 , Pages 1248-1254 , 1 March 2010

Prediction of developing metabolic syndrome after gestational diabetes mellitus

  • Baris Akinci, M.D.

      Affiliations

    • Division of Endocrinology and Metabolism, Department of Internal Medicine, Dokuz Eylul University Medical School, Izmir, Turkey
    • Corresponding Author InformationReprint requests: Baris Akinci, M.D., Division of Endocrinology of Metabolism, Department of Internal Medicine, Dokuz Eylul University Medical School, Inciralti, Izmir, Turkey 35340 (FAX: 90-232-2792267).
    • ,
  • Aygul Celtik, M.D.

      Affiliations

    • Department of Internal Medicine, Dokuz Eylul University Medical School, Izmir, Turkey
    • ,
  • Serkan Yener, M.D.

      Affiliations

    • Division of Endocrinology and Metabolism, Department of Internal Medicine, Dokuz Eylul University Medical School, Izmir, Turkey
    • ,
  • Sena Yesil, M.D.

      Affiliations

    • Division of Endocrinology and Metabolism, Department of Internal Medicine, Dokuz Eylul University Medical School, Izmir, Turkey

Received 24 September 2008 ,Revised 28 November 2008 ,Accepted 3 December 2008.

References 

  1. American Diabetes Association. Standards of medical care in diabetes—2008. Diabetes Care. 2008;31(Suppl 1):S12–S54
  2. O'Sullivan JB. Diabetes mellitus after GDM. Diabetes. 1991;40(Suppl. 2):131–135
  3. Kim C, Newton KM, Knopp RH. Gestational diabetes and the incidence of type 2 diabetes: a systematic review. Diabetes Care. 2002;25:1862–1868
  4. Cheung NW, Byth K. Population health significance of gestational diabetes. Diabetes Care. 2003;26:2005–2009
  5. Henry OA, Beischer NA. Long-term implications of gestational diabetes for the mother. Baillieres Clin Obstet Gynaecol. 1991;5:461–483
  6. DeFronzo RA, Ferrannini E. Insulin resistance. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease. Diabetes Care. 1991;14:173–194
  7. Garvey WT, Hermayer KL. Clinical implications of the insulin resistance syndrome. Clin Cornerstone. 1998;1:13–28
  8. Lann D, LeRoith D. Insulin resistance as the underlying cause for the metabolic syndrome. Med Clin North Am. 2007;91:1063–1077
  9. Ko GT, Chan JC, Tsang LW, Li CY, Cockram CS. Glucose intolerance and other cardiovascular risk factors in chinese women with a history of gestational diabetes mellitus. Aust N Z J Obstet Gynaecol. 1999;39:478–483
  10. Davis CL, Gutt M, Llabre MM, Marks JB, O'Sullivan MJ, Potter JE, et al. History of gestational diabetes, insulin resistance and coronary risk. J Diabetes Complications. 1999;13:216–223
  11. Tam WH, Yang XL, Chan JC, Ko GT, Tong PC, Ma RC, et al. Progression to impaired glucose regulation, diabetes and metabolic syndrome in Chinese women with a past history of gestational diabetes. Diabetes Metab Res Rev. 2007;23:485–489
  12. Lauenborg J, Mathiesen E, Hansen T, Glumer C, Jorgensen T, Borch-Johnsen K, et al. The prevalence of the metabolic syndrome in a Danish population of women with previous gestational diabetes mellitus is three-fold higher than in the general population. J Clin Endocrinol Metab. 2005;90:4004–4010
  13. Verma A, Boney CM, Tucker R, Vohr BR. Insulin resistance syndrome in women with prior history of gestational diabetes mellitus. J Clin Endocrinol Metab. 2002;87:3227–3235
  14. Bo S, Monge L, Macchetta C, Menato G, Pinach S, Uberti B, et al. Prior gestational hyperglycemia: a long-term predictor of the metabolic syndrome. J Endocrinol Invest. 2004;27:629–635
  15. Carpenter MW, Coustan DR. Criteria for screening tests for gestational diabetes. Am J Obstet Gynecol. 1982;144:768–773
  16. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol. Adults (Adult Treatment Panel III). JAMA. 2001;285:2486–2497
  17. Alberti KG, Zimmet P, Shaw J. Metabolic syndrome—a new world-wide definition. A Consensus Statement from the International Diabetes Federation. Diabet Med. 2006;23:469–480
  18. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2008;31(Suppl 1):S55–S60
  19. Clauss A. Rapid physiological coagulation method in determination of fibrinogen. Acta Haematol. 1957;17:237–246
  20. Haffner S, Taegtmeyer H. Epidemic obesity and the metabolic syndrome. Circulation. 2003;108:1541–1545
  21. Albareda M, Caballero A, Badell G, Rodriguez-Espinosa J, Ordonez-Llanos J, de Leiva A, et al. Metabolic syndrome at follow-up in women with and without gestational diabetes mellitus in index pregnancy. Metabolism. 2005;54:1115–1121
  22. Albareda M, Caballero A, Badell G, Piquer S, Ortiz A, de Leiva A, et al. Diabetes and abnormal glucose tolerance in women with previous gestational diabetes. Diabetes Care. 2003;26:1199–1205
  23. Dalfra MG, Lapolla A, Masin M, Giglia G, Dalla Barba B, Toniato R, et al. Antepartum and early postpartum predictors of type 2 diabetes development in women with gestational diabetes mellitus. Diabetes Metab. 2001;27:675–680
  24. Lauenborg J, Hansen T, Jensen DM, Vestergaard H, Molsted-Pedersen L, Hornnes P, et al. Increasing incidence of diabetes after gestational diabetes: a long-term follow-up in a Danish population. Diabetes Care. 2004;27:1194–1199
  25. Buchanan TA. Pancreatic B-cell defects in gestational diabetes: implications for the pathogenesis and prevention of type 2 diabetes. J Clin Endocrinol Metab. 2001;86:989–993
  26. Krishnaveni GV, Hill JC, Veena SR, Geetha S, Jayakumar MN, Karat CL, et al. Gestational diabetes and the incidence of diabetes in the 5 years following the index pregnancy in South Indian women. Diabetes Res Clin Pract. 2007;78:398–404
  27. Unwin N, Shaw J, Zimmet P, Alberti KG. Impaired glucose tolerance and impaired fasting glycaemia: the current status on definition and intervention. Diabet Med. 2002;19:708–723
  28. Langer O. Maternal glycemic criteria for insulin therapy in gestational diabetes mellitus. Diabetes Care. 1998;21(Suppl 2):B91–B98

 B.A. has nothing to disclose. A.C. has nothing to disclose. S.Y. has nothing to disclose. S.Y. has nothing to disclose.

PII: S0015-0282(08)04646-3

doi: 10.1016/j.fertnstert.2008.12.007

Fertility and Sterility
Volume 93, Issue 4 , Pages 1248-1254 , 1 March 2010

Article Tools